Omiya, Japan

Kenji Fujiwara

This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Kogyo Kabushiki Kaisha. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Fujiwara. Retrieved from https://idiyas.com/inventor/kenji-fujiwara-rdp32mb7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Fujiwara: Innovator in Liver Injury Treatment

Introduction

Kenji Fujiwara is a notable inventor based in Omiya, Japan. He has made significant contributions to the field of medical treatment, particularly in addressing liver injuries caused by microorganisms or toxic substances. His innovative approach has the potential to improve patient outcomes in critical health situations.

Latest Patents

Kenji Fujiwara holds a patent for a method for treating liver injury. This method involves administering a composition that includes thrombomodulin, which binds to thrombin and promotes the activation of protein C. This treatment is particularly effective for conditions such as fulminant hepatitis and hepatic veno-occlusive disease (VOD), which can occur after bone marrow transplantation. He has 1 patent to his name.

Career Highlights

Fujiwara is associated with Asahi Kasei Kogyo Kabushiki Kaisha, a company known for its advancements in various fields, including healthcare. His work there has focused on developing innovative solutions to complex medical challenges.

Collaborations

One of his notable coworkers is Satoshi Mochida, with whom he has likely collaborated on various projects aimed at enhancing medical treatments.

Conclusion

Kenji Fujiwara's contributions to the treatment of liver injuries highlight his role as an important inventor in the medical field. His innovative methods have the potential to significantly impact patient care and treatment outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…